Cargando…
Fbxo22 inhibits metastasis in triple-negative breast cancer through ubiquitin modification of KDM5A and regulation of H3K4me3 demethylation
The importance of Fbxo22 in carcinogenesis has been highly documented. Here, we discussed downstream regulatory factors of Fbxo22 in TNBC. RNA-sequencing was conducted for identifying differentially expressed genes, followed by construction of a regulatory network. Expression patterns of Fbxo22/KDM5...
Autores principales: | Li, Siqiaozhi, He, Jinsong, Liao, Xin, He, Yixuan, Chen, Rui, Chen, Junhui, Hu, Sean, Sun, Jia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425479/ https://www.ncbi.nlm.nih.gov/pubmed/36112263 http://dx.doi.org/10.1007/s10565-022-09754-w |
Ejemplares similares
-
KDM4A regulates myogenesis by demethylating H3K9me3 of myogenic regulatory factors
por: Zhu, Qi, et al.
Publicado: (2021) -
SCF(Fbxo22)-KDM4A targets methylated p53 for degradation and regulates senescence
por: Johmura, Yoshikazu, et al.
Publicado: (2016) -
FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21
por: Zhang, Long, et al.
Publicado: (2019) -
RNA-dependent chromatin localization of KDM4D lysine demethylase promotes H3K9me3 demethylation
por: Zoabi, Muhammad, et al.
Publicado: (2014) -
The PHD1 finger of KDM5B recognizes unmodified H3K4 during the demethylation of histone H3K4me2/3 by KDM5B
por: Zhang, Yan, et al.
Publicado: (2014)